Arrol S - Search Results

1

Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease.

Durrington PN, Ishola M, Hunt L, Arrol S, Bhatnagar D. Durrington PN, et al. Among authors: arrol s. Lancet. 1988 May 14;1(8594):1070-3. doi: 10.1016/s0140-6736(88)91895-8. Lancet. 1988. PMID: 2896911

2

A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with type 1 (insulin-dependent) diabetes mellitus.

Winocour PH, Durrington PN, Bhatnagar D, Mbewu AD, Ishola M, Mackness M, Arrol S. Winocour PH, et al. Among authors: arrol s. Diabetes Res Clin Pract. 1992 Dec;18(3):173-84. doi: 10.1016/0168-8227(92)90143-f. Diabetes Res Clin Pract. 1992. PMID: 1289018

3

Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.

Mbewu AD, Bhatnagar D, Durrington PN, Hunt L, Ishola M, Arrol S, Mackness M, Lockley P, Miller JP. Mbewu AD, et al. Among authors: arrol s. Arterioscler Thromb. 1991 Jul-Aug;11(4):940-6. doi: 10.1161/01.atv.11.4.940. Arterioscler Thromb. 1991. PMID: 1829633

4

Postprandial plasma lipoprotein responses to a mixed meal in subjects with hyperapobetalipoproteinaemia.

Bhatnagar D, Durrington PN, Arrol S. Bhatnagar D, et al. Among authors: arrol s. Clin Biochem. 1992 Oct;25(5):341-3. doi: 10.1016/0009-9120(92)80013-7. Clin Biochem. 1992. PMID: 1490296 No abstract available.

5

Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins.

Bhatnagar D, Durrington PN, Mackness MI, Arrol S, Winocour PH, Prais H. Bhatnagar D, et al. Among authors: arrol s. Atherosclerosis. 1992 Jan;92(1):49-57. doi: 10.1016/0021-9150(92)90009-6. Atherosclerosis. 1992. PMID: 1575821 Clinical Trial.

6

Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects.

Tames FJ, Mackness MI, Arrol S, Laing I, Durrington PN. Tames FJ, et al. Among authors: arrol s. Atherosclerosis. 1992 Apr;93(3):237-44. doi: 10.1016/0021-9150(92)90260-n. Atherosclerosis. 1992. PMID: 1590828

7

The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.

Winocour PH, Durrington PN, Bhatagnar D, Ishola M, Mackness M, Arrol S, Anderson DC. Winocour PH, et al. Among authors: arrol s. Atherosclerosis. 1992 Mar;93(1-2):83-94. doi: 10.1016/0021-9150(92)90202-r. Atherosclerosis. 1992. PMID: 1596307 Clinical Trial.

8

Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus.

Winocour PH, Durrington PN, Bhatnagar D, Ishola M, Arrol S, Mackness M. Winocour PH, et al. Among authors: arrol s. Arterioscler Thromb. 1992 Aug;12(8):920-8. doi: 10.1161/01.atv.12.8.920. Arterioscler Thromb. 1992. PMID: 1637789

9

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein.

Mackness MI, Arrol S, Durrington PN. Mackness MI, et al. Among authors: arrol s. FEBS Lett. 1991 Jul 29;286(1-2):152-4. doi: 10.1016/0014-5793(91)80962-3. FEBS Lett. 1991. PMID: 1650712 Free article.

10

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus.

Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN. Mackness MI, et al. Among authors: arrol s. Atherosclerosis. 1991 Feb;86(2-3):193-9. doi: 10.1016/0021-9150(91)90215-o. Atherosclerosis. 1991. PMID: 1651732

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page